CCSD code B2223 – Bilateral laparoscopic adrenalectomy

Key takeaways

CCSD Code B2223 applies only when both adrenal glands are removed laparoscopically in one operative episode. Open, robotic-assisted, and one-gland removals each take a different code.

The four most common indications are bilateral pheochromocytoma, MEN2, ACTH-independent bilateral macronodular adrenal hyperplasia, and Cushing disease refractory to pituitary surgery.

A unilateral ICD-10 diagnosis paired with B2223 is a common denial trigger, so the diagnosis must support bilateral disease.

Robotic-assisted bilateral adrenalectomy has its own code, B2224, so robotic cases should not be billed under B2223.

Pabau’s claims management software lets UK private practices put CCSD codes, ICD-10 diagnoses, and pre-authorization references on one claim, so fewer errors reach the insurer.

CCSD Code B2223: Definition and code details

CCSD Code B2223 is the Clinical Coding and Schedule Development Group’s code for laparoscopic adrenalectomy performed bilaterally. It covers removal of both adrenal glands in one laparoscopic operative episode, by either the transperitoneal or the retroperitoneoscopic route. The code sits in chapter 11 of the CCSD schedule, which covers the abdomen, excluding urinary and reproductive organs.

B2223 belongs to a six-code adrenalectomy family. B2222, B2223 and B2224 cover bilateral removal by open, laparoscopic and robotic-assisted surgery. B2232, B2233 and B2234 cover the same three approaches when only one gland comes out.

Two conditions must both be true for B2223 to apply. First, both adrenal glands must be removed, not one gland with the other left in situ. Second, the whole procedure must be completed with conventional laparoscopic instruments. If either condition is not met, a different code from the family applies.

What the procedure involves: Bilateral laparoscopic adrenalectomy

Bilateral laparoscopic adrenalectomy removes both adrenal glands with minimally invasive keyhole techniques. It usually happens in one continuous operating session and, less commonly, in staged episodes. The two main approaches are transperitoneal, through the abdominal cavity, and posterior retroperitoneoscopic adrenalectomy (PRA). PRA reaches each gland through the back without entering the peritoneum.

The approach matters for documentation rather than code selection. Both routes map to B2223, provided the procedure stays laparoscopic throughout. The operative note must still name the approach used on each side, because insurers use that wording to check the procedure against the submitted code.

• Port placement: typically three to four ports per side, positioned to give the surgeon access to the suprarenal fossa
• Gland mobilization: dissection of periadrenal fat, division of adrenal vessels, and mobilization of each gland in sequence
• Specimen retrieval: both specimens removed in endoscopic retrieval bags to prevent rupture, which matters most for pheochromocytoma
• Closure: port sites closed, with no open incision unless conversion occurred
• Hemodynamic monitoring: bilateral pheochromocytoma requires specialist anesthetic management, which must be documented separately

Patients who have both adrenal glands removed become permanently adrenally insufficient, because they lose all their own cortisol and aldosterone production. Lifelong glucocorticoid and mineralocorticoid replacement starts straight after surgery. That permanence is why insurers treat the operation as irreversible and scrutinize the pre-authorization request so closely.

Clinical indications covered by B2223

B2223 is reserved for conditions that require removal of both adrenal glands. The diagnosis must support bilateral disease, because a single-gland finding cannot justify a bilateral procedure code. The four main indications accepted by UK private medical insurers are listed below.

Adrenal cortical carcinoma that needs bilateral resection is a less common indication. When it applies, document pathological involvement of both sides in the pre-operative imaging and the MDT record.

How B2223 fits within the CCSD adrenalectomy code family

The CCSD adrenalectomy family has six codes. Laterality sets the first split, one gland or both, and the approach sets the second: open, laparoscopic or robotic-assisted. Picking the wrong cell is the most preventable billing error in adrenal surgery, and the grid below shows where B2223 sits.

The table below maps each code, so coders can confirm the choice before submission.

If only one gland comes out, the claim moves to the unilateral codes: B2232 for open surgery, B2233 for laparoscopic and B2234 for robotic-assisted. Descriptors are revised from time to time, so check the live CCSD schedule before you submit.

For the wider coding framework, browse our CCSD billing guides or the Bupa CCSD codes walkthrough.

ICD-10 diagnosis codes to submit alongside B2223

Every B2223 claim needs a matching ICD-10 diagnosis code that confirms the clinical reason for bilateral adrenal removal. The diagnosis must reflect bilateral or systemic disease. A single-gland tumor, such as D35.0 documented on one side only, paired with B2223 is likely to be denied by most insurers.

For UK ICD-10 lookups, the NHS Classifications Browser is the authoritative reference for the ICD-10 5th edition.

Documentation requirements: What the operative note must include

The operative note is the document insurers scrutinize most when they review a B2223 claim. An incomplete note is one of the most frequent reasons these claims are returned.

Private practice managers should build a structured operative note checklist into their pre-submission workflow. The wider principles of billing compliance set the documentation standards for every CCSD surgical claim.

• Bilateral confirmation: the note must state that both adrenal glands were removed. Phrases such as “right adrenal gland excised; left adrenal gland excised” are clearer than “bilateral adrenalectomy performed.”
• Approach specified per side: document whether each side was completed transperitoneally or via PRA. If the approaches differed between sides, note both.
• Port placement: the number and position of ports on each side, confirming no open incision was made.
• Specimen details: the weight and dimensions of each gland, plus a macroscopic description. Insurers use this to cross-check pathology against the submitted diagnosis code.
• Hemostasis confirmation: confirmation that bleeding was controlled laparoscopically, with no conversion to open required.
• Conversion event: any conversion must be documented straight away, because it triggers a recoding review.
• Surgeon identity and date: the consultant’s name, grade, and operative date. The anesthetic team is documented separately.

Pre-authorization for CCSD Code B2223: What insurers require

Bilateral laparoscopic adrenalectomy almost always needs pre-authorization from the patient’s insurer before surgery. Because the operation leaves the patient permanently adrenally insufficient, insurers treat it as a major, irreversible intervention and apply extra clinical scrutiny. Contact the insurer as soon as the decision to operate is made, ideally at least two weeks before the surgery date.

Each insurer has its own portal and timeline. Bupa uses its code search portal for procedure verification. AXA Health handles pre-authorization through its specialist forms portal. Aviva sets out its requirements in its practitioner fee schedule. Portals, required documents, and timelines differ, so never treat one insurer’s rule as universal.

• Step 1: Confirm the patient’s policy covers bilateral adrenalectomy, and identify the pre-authorization pathway for their insurer.
• Step 2: Prepare the clinical evidence pack. Most insurers want CT or MRI imaging of both adrenals before surgery. They also want biochemistry confirming bilateral disease, such as 24-hour urinary catecholamines, cortisol studies, and ACTH levels. Add a consultant endocrine surgeon’s letter stating the indication and planned approach.
• Step 3: For refractory Cushing disease, include evidence of failed pituitary surgery, meaning the operative note and post-operative cortisol results. Most insurers require this before they will authorize bilateral removal.
• Step 4: Submit the pre-authorization request and record the reference number, because it must appear on the final claim form. A missing reference number is a frequent denial trigger, even when the clinical case is strong.
• Step 5: Confirm the pre-authorization covers both the surgeon’s and the anesthetist’s fees. Anesthetic pre-authorization is sometimes processed separately.

Common claim denial reasons for B2223 and how to avoid them

B2223 claims draw close scrutiny because the code is procedure-specific, the clinical threshold is high, and the documentation is detailed. Effective denial management starts before the patient reaches the operating room, not after the claim comes back. The table below maps the most common denial triggers to the action that prevents each one.

Conversion to open surgery: When to recode from B2223

When a laparoscopic bilateral adrenalectomy converts to open during the operative episode, the submitted code must change. B2223 covers laparoscopic bilateral removal only, so a change of approach means a change of code.

The recoding rule is less obvious in bilateral surgery, because conversion may affect one side or both. Apply these rules:

• Both sides converted to open: recode as B2222 (open bilateral adrenalectomy) and do not keep B2223. The final approach across the whole procedure was open, and billing the laparoscopic code is a coding inaccuracy an audit will catch.
• One side completed laparoscopically, one side converted: no single CCSD code covers a hybrid bilateral approach. Document the exact events in the operative note, and get written confirmation from the insurer’s medical reviewer before submitting. Some insurers accept B2222 for the whole episode, while others ask for itemized justification. Confirm first rather than assume.
• Conversion documented but code not updated: this is the most common audit finding linked to B2223. Correcting it means resubmitting with the updated code and a clinical rationale letter.

Robotic-assisted bilateral adrenalectomy: Use B2224, not B2223

Robotic-assisted bilateral adrenalectomy has its own CCSD code, B2224, so robotic cases should be billed under B2224 rather than B2223. B2223 is for conventional laparoscopic removal of both glands. The unilateral family follows the same pattern, with B2234 for robotic-assisted removal of one gland.

Robotic systems such as da Vinci are increasingly used at specialist UK centers, and some insurers apply their own pre-authorization rules to robotic surgery. Name the planned approach in the request, for example “robotic-assisted bilateral adrenalectomy,” and quote B2224. That puts the insurer on notice before surgery and prevents a post-submission query that can add weeks to payment.

The operative note must then confirm that the robot was used on each side. A robotic note submitted under B2223, or a laparoscopic note under B2224, is a code mismatch the insurer will query.

Billing CCSD Code B2223 in private practice: Step-by-step guide

Private practices submitting B2223 claims benefit from a standard pre-submission workflow. Each step below targets a common failure point in the medical billing process.

1. Obtain pre-authorization. Send the insurer’s pre-authorization team the imaging, biochemistry, and the consultant’s indication letter. Confirm the approval covers both surgical and anesthetic fees. Record the reference number in the patient’s billing record straight away.
2. Confirm the CCSD code. Review the operative plan with the surgeon before the procedure date. Confirm both glands are planned for removal and the approach is conventional laparoscopic. Select B2223 provisionally, subject to revision if conversion occurs.
3. Complete the operative note checklist. Before the patient leaves the operating room, check the note. It must cover bilateral removal in text, approach per side, port placement, specimen weights, hemostasis, and conversion status.
4. Select and pair the ICD-10 code. Choose the principal ICD-10 diagnosis code that reflects bilateral or systemic disease, using the reference table above. Add any secondary codes for MEN2 status or coexisting endocrine conditions.
5. Attach all supporting documents. Include the pre-authorization letter, imaging reports, biochemistry summary, and MDT decision letter where required. Most insurers accept digital attachments through their claims portals.
6. Submit within the insurer’s claim window. Most UK private medical insurers require submission within 90 to 180 days of the procedure date. Check the window for each insurer, because it varies.
7. Keep a complete copy for audit. Store the operative note, claim form, pre-authorization reference, and every attachment in the patient’s billing file. Bilateral adrenalectomy claims are high-value, so expect insurers to audit them closely.

How Pabau keeps B2223 claims accurate from note to insurer

Many practices still assemble a B2223 claim by hand. Someone copies the code from the operative plan, looks up the diagnosis, and digs the pre-authorization reference out of an email. Each retyped field is another chance for a unilateral code or a missing reference to reach the insurer.

Pabau’s claims management software pulls the patient, treatment, and insurer details from the patient record into a pre-filled submission. You review it and send it to Healthcode without leaving Pabau. For insurers not on Healthcode, the claim goes out by email with the invoice attached.

Every claim then moves through clear stages: Pending, Submitted, Processing, and Paid or Error. A returned B2223 claim shows up straight away. Your team can then fix the code or attach the missing letter while the case is fresh.

Streamline your CCSD billing workflow

Pabau helps UK private practices attach CCSD procedure codes, ICD-10 diagnoses, and pre-authorization references to one digital claim record. That cuts the submission errors behind B2223 denials.

Book a demo

Conclusion

B2223 is only correct when the operative note proves two facts: both adrenal glands came out, and both sides stayed laparoscopic. If either fact is missing, the claim belongs to a sibling code, and the insurer will spot it before payment.

So settle the code before surgery rather than after a denial. Confirm laterality and approach with the surgeon, quote B2224 at pre-authorization if the robot is planned, and recheck the note for conversion before you submit. That routine takes minutes and protects a high-value claim that insurers check closely.

Book a demo to see how Pabau carries the code, diagnosis, and pre-authorization reference onto one clean B2223 claim.

Continue your research

Billing another bilateral endocrine operation? CCSD code B0820 is the billing guide for bilateral subtotal thyroidectomy in UK private practice.

Need the insurer fee before you quote a self-pay or insured patient? The Bupa procedure codes and fee schedule guide sets out how Bupa prices CCSD codes and where to look up each one.

Want to confirm a patient’s cover before you book surgery? Insurance eligibility verification walks through checking coverage before every visit, so a claim never starts on a lapsed policy.

Looking to cut the time spent writing operative notes? AI clinical documentation explains how AI drafts notes that still record the detail insurers check on a claim.

Frequently asked questions